Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens
Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens
复制标题
DOI:
10.1167/iovs.05-1547
复制
发表时间:
2006-06-01
影响因子:
4.4
通讯作者:
Mochizuki, Manabu
中科院分区:
文献类型:
--
作者:
Sugita, Sunao;Takase, Hiroshi;Mochizuki, Manabu
PURPOSE. To determine whether, patients with Vogt-Koyanagi-Harada (VKH) disease have immune responses specific to the melanocyte antigens tyrosinase and gp100.METHODS. T-cell clones (TCCs) were established from cells infiltrating the aqueous humor and from peripheral blood mononuclear cells (PBMCs) of patients with VKH. The target cells were LDR4-transfected cells (HLA-DRB1*0405). The TCCs were cocultured with LDR4 in the presence of tyrosinase (tyrosinase(450-462): SYLQDSDPDSFQD), gp100 (9000(44-59): WN-RQLYPEWTEAQRLD), or a control peptide. The immune response was evaluated by cytokine production. The responding melanocyte peptide-specific VKH-TCCs were characterized by an immunofluorescence method with flow cytometry. A search was made for molecular mimicry among tyrosinase450-462, gp100(44-59), and exogenous antigens, such as viruses, by database screening.RESULTS. Cells infiltrating the eye and PBMCs in HLA-DR4(+) (HLA-DRB1*0405, 0410) patients with VKH contained a population of CD4(+) T lymphocytes that recognized tyrosinase and gp100 peptides and produced RANTES and IFN-gamma in response to the two peptides. The T cells were active memory Th1-type lymphocytes, and they recognized the tyrosinase peptide and produced IFN-gamma in response to HfA-DRB1*0405(+) melanoma cells. Cytornegalovirus envelope glycoprotein H (CMV-egH(290-302)) had high amino acid homology with the tyrosinase peptide. In addition, some of the VKH-TCCs recognized CMV-egH(290-302) peptide, as well as the tyrosinase peptides.CONCLUSIONS. In VKH there are tyrosinase and-gp100 peptide-specific T cells that can mediate an inflammatory response. Such melanocyte antigen-specific T cells could be associated with the cause and pathology of VKH disease.